Zhang and colleagues are to be complimented for recently conducting an interesting study that compared the perioperative outcomes of two-stage robot-assisted minimally invasive esophagectomy (RAMIE) versus two-stage conventional minimally invasive esophagectomy (MIE). 1 In that study, it was concluded that RAMIE and MIE are similar regarding intraoperative blood loss, postoperative complications, length of hospital stay, and lymph node yield; however, the operating time was significantly longer in the RAMIE group. These findings are a valuable addition to the existing evidence for RAMIE and we would like to place this into a broader perspective. Although open esophagectomy is still the worldwide standard, MIE is increasingly applied, aiming to decrease surgical trauma and ultimately improve postoperative outcomes in terms of postoperative complications. This paradigm shift is largely based on evidence from case series and a randomized controlled trial, which indicated that MIE may be superior to open esophagectomy in terms of intraoperative blood loss, postoperative pulmonary complications, length of hospital stay, and quality of life. 2 However, several recent population-based studies have reported a higher re-intervention rate in patients who underwent MIE, while no evident reduction in postoperative pulmonary complications or overall morbidity was observed. 3-6 It was postulated that these findings might be explained by the learning curve of MIE as the early adaptation phase was within the inclusion years for most